Colchicine in atrial fibrillation: are old trees in bloom?

Frontiers in Physiology

Physiology

Juan Tang¹  Honghua Yue²  Yujia Zhan²  Xueshan Zhao²  Zhong Wu² 

[1] Acupuncture and Moxibustion School of Teaching, Hospital of Chengdu, University of Traditional Chinese Medicine, Tianjin, China;Key Laboratory of Emergency and Trauma, Ministry of Education, Hainan Medical University, Haikou, China;Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China;

关键词: colchicine;    atrial fibrillation;    postoperative atrial fibrillation;    inflammation;    NLRP3 inflammasome;   

DOI  :  10.3389/fphys.2023.1260774

 received in 2023-07-18, accepted in 2023-09-26,  发布年份 2023

来源: Frontiers

【 摘 要 】

Colchicine is a widely used drug that was originally used to treat gout and rheumatic diseases. In recent years, colchicine has shown high potential in the cardiovascular field. Atrial fibrillation (AF) is a cardiovascular disease with a high incidence. One of the most frequent complications following cardiovascular surgery is postoperative atrial fibrillation (POAF), which affects patient health and disease burden. This article reviews the research status of colchicine in AF and summarizes the relevant progress.

【 授权许可】

Unknown   
Copyright © 2023 Zhan, Yue, Zhao, Tang and Wu.